How Biopharma Leaders are Redefining Partnership Across the Lifecycle

Home | Knowledge Center | Resource Library | How Biopharma Leaders are Redefining Partnership Across the Lifecycle

As biopharma programs become more complex, delivering therapies at scale requires deeper collaboration across industry, infrastructure, and global supply networks. In this panel discussion, leaders from Johnson & Johnson, Regeneron, Jacobs, and FUJIFILM Biotechnologies share how effective partnerships are built and sustained across process development, scale-up, and commercial manufacturing. From aligning early to adapting as programs grow, the conversation explores how strong partnerships help reduce risk, expand capabilities, and accelerate therapies to patients. Watch to hear how leading organizations are turning partnership into a strategic advantage.

Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy